/
Serum Institute of India Gets DCGI’s Green Signal To Resume Phase 2-3 Trials For Oxford-AstraZeneca Covid-19 Vaccine

Serum Institute of India Gets DCGI’s Green Signal To Resume Phase 2-3 Trials For Oxford-AstraZeneca Covid-19 Vaccine

<b>Amidst desperate attempts made by the global medical fraternity to get a full proof coronavirus vaccine after many endeavors failing at the final hurdle and most critical stages of research, the Serum Institute of India (SII) is all geared up to commence its phase two and three clinical trials for